Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypertension and Regulation of Blood Pressure

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...

Hypertension I: Introduction

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...

Antihypertensive Drugs: Potassium-Sparing Diuretics

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prevalence, awareness and therapeutic control of hypertension in Belgium: an opportunistic screening of nearly 6,000 participants during the May Measurement Month campaigns 2017-23.

Blood pressure·2025

Same author

[About the purple urine bag syndrome].

Revue medicale de Liege·2021

Same author

[Autosomal dominant polycystic kidney disease : a pediatric perspective].

Revue medicale de Liege·2020

Same author

[COVID-19 inside dialysis units].

Revue medicale de Liege·2020

Same author

[Kidney injury in COVID-19].

Revue medicale de Liege·2020

Same author

[Arguments for a role of the gut microbiota in the pathophysiology of hypertension].

Revue medicale de Liege·2020

Search research articles

Related Experiment Video

Updated: Jul 15, 2026

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method

Published on: May 22, 2019

Hypertension and the kidney.

J M Krzesinski¹, E P Cohen

¹Division of Nephrology/Transplantation, University of Liège, Sart Titman B35, Belgium. jm.krzesinski@chu.ulg.ac.be

Acta Clinica Belgica

|April 25, 2007

Summary

Essential hypertension and kidney disease are closely linked, with high blood pressure accelerating kidney failure. Aggressive blood pressure management is crucial for patients with chronic kidney disease, especially using renin-angiotensin axis blockers.

Area of Science:

Nephrology
Cardiology
Hypertension Research

Background:

The kidney can be a cause of essential hypertension, leading to renal disease.
Hypertension is prevalent in chronic kidney disease (CKD) and accelerates kidney failure.
A strong link exists between hypertension and kidney health.

Purpose of the Study:

To emphasize the critical link between hypertension and kidney disease.
To advocate for aggressive blood pressure control in CKD patients.
To highlight the benefits of specific antihypertensive drug classes.

Main Methods:

Review of existing literature on hypertension and kidney disease.
Analysis of blood pressure goals in CKD patients.
Evaluation of antihypertensive drug classes, focusing on renin-angiotensin axis blockers.

Related Experiment Videos

Last Updated: Jul 15, 2026

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method

Published on: May 22, 2019

Main Results:

Hypertension is a significant risk factor for CKD progression.
Recommended blood pressure goal for CKD patients is <130/80 mmHg, or <125/75 mmHg with proteinuria >1g/day.
Renin-angiotensin axis blockers provide nephroprotective and cardioprotective benefits beyond blood pressure reduction.

Conclusions:

Aggressive hypertension management is vital for CKD patients.
Specific blood pressure targets should be individualized based on proteinuria.
Renin-angiotensin axis blockers are recommended for their dual protective effects.